Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Apr;80(1-2):127–132. doi: 10.1038/sj.bjc.6690331

Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells

K Takenaga 1
PMCID: PMC2362998  PMID: 10389988

Abstract

S100A4 belongs to the S100 subfamily of calcium-binding proteins and has been suggested to be directly involved in invasion and metastasis of rodent and human tumour cells. The present study demonstrates that interferon gamma (IFN-γ), but not IFN-α and IFN-β, down-regulates the S100A4 mRNA level in colon adenocarcinoma WiDr cells in time- and dose-dependent manners. The effect was not associated with any cytotoxicity and was specific for the S100A4 mRNA, since the levels of the S100A6 and GAPDH mRNAs were not significantly affected by the treatment. IFN-γ also strongly suppressed the S100A4 mRNA expression in HT-29 cells, but weakly in Colo201 cells. Flow cytometric analysis revealed that the level of the IFN-γ receptor expression in Colo201 cells was lower than that in WiDr and HT-29 cells, suggesting that the suppression of the S100A4 expression by IFN-γ depends on the amount of cell surface IFN-γ receptor protein. IFN-γ had no effect on the transcription rate of the S100A4 gene but reduced the stability of the S100A4 mRNA. WiDr cells treated with IFN-γ showed reduced motile ability, further supporting the assumption that the S100A4 gene product is involved in controlling cell motility. © 1999 Cancer Research Campaign

Keywords: IFN-γ, S100A4, IFN-γ-receptor, motility, colon carcinoma

Full Text

The Full Text of this article is available as a PDF (205.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. An Z., Wang X., Astoul P., Danays T., Moossa A. R., Hoffman R. M. Interferon gamma is highly effective against orthotopically-implanted human pleural adenocarcinoma in nude mice. Anticancer Res. 1996 Sep-Oct;16(5A):2545–2551. [PubMed] [Google Scholar]
  2. Barraclough R., Savin J., Dube S. K., Rudland P. S. Molecular cloning and sequence of the gene for p9Ka. A cultured myoepithelial cell protein with strong homology to S-100, a calcium-binding protein. J Mol Biol. 1987 Nov 5;198(1):13–20. doi: 10.1016/0022-2836(87)90453-0. [DOI] [PubMed] [Google Scholar]
  3. Besançon F., Przewlocki G., Baró I., Hongre A. S., Escande D., Edelman A. Interferon-gamma downregulates CFTR gene expression in epithelial cells. Am J Physiol. 1994 Nov;267(5 Pt 1):C1398–C1404. doi: 10.1152/ajpcell.1994.267.5.C1398. [DOI] [PubMed] [Google Scholar]
  4. Bourgeade M. F., Silbermann F., Kühn L., Testa U., Peschle C., Mémet S., Thang M. N., Besançon F. Post-transcriptional regulation of transferrin receptor mRNA by IFN gamma. Nucleic Acids Res. 1992 Jun 25;20(12):2997–3003. doi: 10.1093/nar/20.12.2997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davies B. R., Davies M. P., Gibbs F. E., Barraclough R., Rudland P. S. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene. 1993 Apr;8(4):999–1008. [PubMed] [Google Scholar]
  6. Ebralidze A., Tulchinsky E., Grigorian M., Afanasyeva A., Senin V., Revazova E., Lukanidin E. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. Genes Dev. 1989 Jul;3(7):1086–1093. doi: 10.1101/gad.3.7.1086. [DOI] [PubMed] [Google Scholar]
  7. Ford H. L., Salim M. M., Chakravarty R., Aluiddin V., Zain S. B. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene. 1995 Nov 16;11(10):2067–2075. [PubMed] [Google Scholar]
  8. Ford H. L., Zain S. B. Interaction of metastasis associated Mts1 protein with nonmuscle myosin. Oncogene. 1995 Apr 20;10(8):1597–1605. [PubMed] [Google Scholar]
  9. Goldring M. B., Fukuo K., Birkhead J. R., Dudek E., Sandell L. J. Transcriptional suppression by interleukin-1 and interferon-gamma of type II collagen gene expression in human chondrocytes. J Cell Biochem. 1994 Jan;54(1):85–99. doi: 10.1002/jcb.240540110. [DOI] [PubMed] [Google Scholar]
  10. Goto K., Endo H., Fujiyoshi T. Cloning of the sequences expressed abundantly in established cell lines: identification of a cDNA clone highly homologous to S-100, a calcium binding protein. J Biochem. 1988 Jan;103(1):48–53. doi: 10.1093/oxfordjournals.jbchem.a122237. [DOI] [PubMed] [Google Scholar]
  11. Grigorian M. S., Tulchinsky E. M., Zain S., Ebralidze A. K., Kramerov D. A., Kriajevska M. V., Georgiev G. P., Lukanidin E. M. The mts1 gene and control of tumor metastasis. Gene. 1993 Dec 15;135(1-2):229–238. doi: 10.1016/0378-1119(93)90070-j. [DOI] [PubMed] [Google Scholar]
  12. Grigorian M., Ambartsumian N., Lykkesfeldt A. E., Bastholm L., Elling F., Georgiev G., Lukanidin E. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer. 1996 Sep 17;67(6):831–841. doi: 10.1002/(SICI)1097-0215(19960917)67:6<831::AID-IJC13>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  13. Grigorian M., Tulchinsky E., Burrone O., Tarabykina S., Georgiev G., Lukanidin E. Modulation of mts1 expression in mouse and human normal and tumor cells. Electrophoresis. 1994 Mar-Apr;15(3-4):463–468. doi: 10.1002/elps.1150150163. [DOI] [PubMed] [Google Scholar]
  14. Groudine M., Peretz M., Weintraub H. Transcriptional regulation of hemoglobin switching in chicken embryos. Mol Cell Biol. 1981 Mar;1(3):281–288. doi: 10.1128/mcb.1.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Harel-Bellan A., Brini A. T., Farrar W. L. IFN-gamma inhibits c-myc gene expression by impairing the splicing process in a colony-stimulating factor dependent murine myeloid cell line. J Immunol. 1988 Aug 1;141(3):1012–1017. [PubMed] [Google Scholar]
  16. Ilg E. C., Schäfer B. W., Heizmann C. W. Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer. 1996 Nov 4;68(3):325–332. doi: 10.1002/(SICI)1097-0215(19961104)68:3<325::AID-IJC10>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  17. Jackson-Grusby L. L., Swiergiel J., Linzer D. I. A growth-related mRNA in cultured mouse cells encodes a placental calcium binding protein. Nucleic Acids Res. 1987 Aug 25;15(16):6677–6690. doi: 10.1093/nar/15.16.6677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kriajevska M. V., Cardenas M. N., Grigorian M. S., Ambartsumian N. S., Georgiev G. P., Lukanidin E. M. Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene. J Biol Chem. 1994 Aug 5;269(31):19679–19682. [PubMed] [Google Scholar]
  19. Maelandsmo G. M., Hovig E., Skrede M., Engebraaten O., Flørenes V. A., Myklebost O., Grigorian M., Lukanidin E., Scanlon K. J., Fodstad O. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res. 1996 Dec 1;56(23):5490–5498. [PubMed] [Google Scholar]
  20. Masumori N., Tsukamoto T., Kumamoto Y. Interferon-gamma and interleukin-2 suppress the experimental metastasis of mouse renal adenocarcinoma. Int J Urol. 1995 Mar;2(1):6–11. doi: 10.1111/j.1442-2042.1995.tb00612.x. [DOI] [PubMed] [Google Scholar]
  21. McMillan T. J., Rao J., Everett C. A., Hart I. R. Interferon-induced alterations in metastatic capacity, class-1 antigen expression and natural killer cell sensitivity of melanoma cells. Int J Cancer. 1987 Nov 15;40(5):659–663. doi: 10.1002/ijc.2910400515. [DOI] [PubMed] [Google Scholar]
  22. Nakamura N., Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis. 1998 Jul;16(5):471–479. doi: 10.1023/a:1006589626307. [DOI] [PubMed] [Google Scholar]
  23. Ossina N. K., Cannas A., Powers V. C., Fitzpatrick P. A., Knight J. D., Gilbert J. R., Shekhtman E. M., Tomei L. D., Umansky S. R., Kiefer M. C. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem. 1997 Jun 27;272(26):16351–16357. doi: 10.1074/jbc.272.26.16351. [DOI] [PubMed] [Google Scholar]
  24. Parker C., Whittaker P. A., Usmani B. A., Lakshmi M. S., Sherbet G. V. Induction of 18A2/mts1 gene expression and its effects on metastasis and cell cycle control. DNA Cell Biol. 1994 Oct;13(10):1021–1028. doi: 10.1089/dna.1994.13.1021. [DOI] [PubMed] [Google Scholar]
  25. Pedrocchi M., Schäfer B. W., Mueller H., Eppenberger U., Heizmann C. W. Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int J Cancer. 1994 Jun 1;57(5):684–690. doi: 10.1002/ijc.2910570513. [DOI] [PubMed] [Google Scholar]
  26. Radinsky R. Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev. 1995 Dec;14(4):323–338. doi: 10.1007/BF00690601. [DOI] [PubMed] [Google Scholar]
  27. Radzioch D., Varesio L. c-fos mRNA expression in macrophages is downregulated by interferon-gamma at the posttranscriptional level. Mol Cell Biol. 1991 May;11(5):2718–2722. doi: 10.1128/mcb.11.5.2718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Raitano A. B., Korc M. Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors. Cancer Res. 1993 Feb 1;53(3):636–640. [PubMed] [Google Scholar]
  29. Ramani P., Balkwill F. R. Enhanced metastases of a mouse carcinoma after in vitro treatment with murine interferon gamma. Int J Cancer. 1987 Dec 15;40(6):830–834. doi: 10.1002/ijc.2910400621. [DOI] [PubMed] [Google Scholar]
  30. Schäfer B. W., Heizmann C. W. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci. 1996 Apr;21(4):134–140. doi: 10.1016/s0968-0004(96)80167-8. [DOI] [PubMed] [Google Scholar]
  31. Sen G. C., Lengyel P. The interferon system. A bird's eye view of its biochemistry. J Biol Chem. 1992 Mar 15;267(8):5017–5020. [PubMed] [Google Scholar]
  32. Strutz F., Okada H., Lo C. W., Danoff T., Carone R. L., Tomaszewski J. E., Neilson E. G. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 1995 Jul;130(2):393–405. doi: 10.1083/jcb.130.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Takenaga K., Nakamura Y., Endo H., Sakiyama S. Involvement of S100-related calcium-binding protein pEL98 (or mts1) in cell motility and tumor cell invasion. Jpn J Cancer Res. 1994 Aug;85(8):831–839. doi: 10.1111/j.1349-7006.1994.tb02955.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Takenaga K., Nakamura Y., Sakiyama S. Cellular localization of pEL98 protein, an S100-related calcium binding protein, in fibroblasts and its tissue distribution analyzed by monoclonal antibodies. Cell Struct Funct. 1994 Jun;19(3):133–141. doi: 10.1247/csf.19.133. [DOI] [PubMed] [Google Scholar]
  35. Takenaga K., Nakamura Y., Sakiyama S. Expression of a calcium binding protein pEL98 (mts1) during differentiation of human promyelocytic leukemia HL-60 cells. Biochem Biophys Res Commun. 1994 Jul 15;202(1):94–101. doi: 10.1006/bbrc.1994.1898. [DOI] [PubMed] [Google Scholar]
  36. Takenaga K., Nakamura Y., Sakiyama S. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene. 1997 Jan 23;14(3):331–337. doi: 10.1038/sj.onc.1200820. [DOI] [PubMed] [Google Scholar]
  37. Takenaga K., Nakanishi H., Wada K., Suzuki M., Matsuzaki O., Matsuura A., Endo H. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2309–2316. [PubMed] [Google Scholar]
  38. Yanagihara K., Seyama T., Watanabe Y. Antitumor potential of interferon-gamma: retroviral expression of mouse interferon-gamma cDNA in two kinds of highly metastatic mouse tumor lines reduces their tumorigenicity. Nat Immun. 1994 Mar-Jun;13(2-3):102–112. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES